Stifel Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Stifel Financial's VCYT Position: Q1 2026 in Review
Stifel Financial reduced its Veracyte (VCYT) stake by 38% in Q1 2026, selling an estimated $677K and leaving 30,037 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.
Stifel Financial first reported a position in VCYT in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.03M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Stifel Financial held 30,037 shares of Veracyte worth $967K as of Q1 2026.
- Stifel Financial sold 18,289 Veracyte shares in Q1 2026, an estimated $677K.
- Veracyte made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2478 holding.
- Stifel Financial first reported a position in Veracyte in Q2 2019 and has held it in 28 quarters since.
- Stifel Financial's Veracyte position peaked at $2.03M in Q4 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.